2B70:F:F-iShares NASDAQ US Biotechnology UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.455

Change

0.00 (0.00)%

Market Cap

USD 0.52B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

Largest Industry Peers for Others

ETFs Containing 2B70:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.29% 74% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.29% 71% C- 60% D-
Trailing 12 Months  
Capital Gain 19.94% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.94% 70% C- 64% D
Trailing 5 Years  
Capital Gain 54.33% 72% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.33% 71% C- 57% F
Average Annual (5 Year Horizon)  
Capital Gain 5.60% 61% D- 62% D
Dividend Return 5.60% 59% D- 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.77% 48% F 78% C+
Risk Adjusted Return 40.65% 56% F 64% D
Market Capitalization 0.52B 60% D- 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.